Skip to main content
. 2020 Feb 19;19:22. doi: 10.1186/s12933-020-00998-6

Table 6.

Associations of continuous and dichotomous mtDNA 8-OHdG with 1-year outcomes after coronary revascularization

Outcomes Continuous mtDNA 8-OHdG Dichotomous mtDNA 8-OHdG
HR (95%CI)a Pa No. of eventsb HR (95%CI)a Pa
High (n = 344) Low (n = 357)
MACCE 1.59 (1.33–1.90) < 0.001 78 (22.7) 31 (8.7) 2.74 (1.80–4.17) < 0.001
All-cause death 2.06 (1.59–2.66) < 0.001 34 (9.9) 11 (3.1) 3.36 (1.69–6.69) < 0.001
Cardiac death 1.92 (1.33–2.78) < 0.001 19 (5.5) 5 (1.4) 3.80 (1.40–10.3) 0.009
Repeat revascularization 1.26 (0.98–1.62) 0.078 47 (13.7) 19 (5.3) 2.67 (1.55–4.57) < 0.001
Non-fatal MI 1.42 (0.91–2.22) 0.126 12 (3.5) 7 (2.0) 2.30 (0.89–5.92) 0.085
Non-fatal stroke 1.45 (0.59–3.58) 0.417 3 (0.9) 2 (0.6) 1.71 (0.27–10.8) 0.569

MACCE major adverse cardiovascular and cerebral events, MI myocardial infarction

aModels were adjusted for age, sex, smoking habit, alcohol drinking habit, overweight/obesity, hypertension, dyslipidemia., FPG, HbA1c, diabetes duration, and type of diabetes management

bThe cutoff that categorized the value of mtDNA 8-OHdG as high or low was 3.22 ∆ct based on the results of time-dependent ROC